胃息肉内镜下治疗患者临床路径变异因素研究  

Variation Factors of Clinical Pathway in Patients With Gastric Polyps Treated by Endoscopy

作　　者：张莉莉 夏淑晶 成凤干 倪克乾 邹德铜 ZHANG Lili;XIA Shujing;CHENG Fenggan;NI Keqian;ZOU Detong(Department of Gastroenterology, Xinghua City People's Hospital, Xinghua Jiangsu 225700, China)

机构地区：[1]兴化市人民医院消化内科,江苏兴化225700

出　　处：《中国继续医学教育》2019年第14期105-108,共4页China Continuing Medical Education

摘　　要：目的分析胃息肉临床路径变异因素,提出干预措施,为临床路径变异的干预研究提供理论依据和经验支持。方法回顾性分析2016年6月—2017年12月胃息肉患者的临床资料,并对变异因素进行logistic回归分析。结果 803例胃息肉患者中,临床路径变异者为144例,变异率为17.93%,其中正性变异为32例(22.22%),负性变异为112例(77.78%);45例(5.60%)退出路径,患方因素是患者退出临床路径的主要因素。结论通过对临床路径变异因素的分析及干预,可以减少变异的发生,实现医院和患方的双赢。Objective To analyze variable factors in the clinical pathway of gastric polyps and propose intervention, providing theoretical basis and empirical supports for intervention research of clinical pathway variation. Methods The clinical data of patients with gastric polyps from June 2016 to December 2017 were retrospectively analyzed, and logistic regression analysis was performed for the variables. Results There were 144 cases of clinical pathway variation in 803 cases of patients with gastric interest, and the rate of variation was 17.93%, including 32 cases of positive variation(22.22%) and 112 cases of negative variation(77.78%). 45 patients(5.60%) withdrew from the clinical pathway, with the patient’s cause as the main factor. Conclusion Through the continuous improvement of the clinical pathway process design, the strengthening of the pathway implementation management process and the full evaluation of patients’ conditions, we can reduce the occurrence of variation, continuously improve the quality of clinical management, and maximize the rehabilitation benefits of patients.

关 键 词：胃息肉 临床路径 变异分析 治疗 因素 研究 

分 类 号：R656[医药卫生—外科学]